Cullen/Frost Bankers, Inc.
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 39263
San Antonio, TX
Position in REGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$640,999
-$191,134 QoQ
Shares Held
1,028
-4.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#156
of 374 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cullen/Frost Bankers, Inc. holds $19,437,519 across 25 Biotechnology names. REGN ranks #4 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,291 | $9,085,688 | |
| 2 | INSM |
INSMED Inc
|
54,740 | $5,836,378 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,977 | $3,304,406 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,028 | $640,999 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
3,868 | $136,888 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,148 | $116,872 | |
| 7 | RPRX |
Royalty Pharma plc
|
2,016 | $113,037 | |
| 8 | ARGX |
Argenx SE
|
74 | $68,654 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $640,999 | 1,028 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $832,133 | 1,077 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $331,904 | 430 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $291,818 | 519 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $3,372,075 | 6,423 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $4,355,891 | 6,868 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $4,492,665 | 6,307 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $493,031 | 469 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $448,789 | 427 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $313,771 | 326 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $278,417 | 317 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $277,337 | 337 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $206,220 | 287 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $268,686 | 327 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $235,927 | 327 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $246,615 | 358 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $174,974 | 296 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $209,526 | 300 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $189,456 | 300 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $179,133 | 296 | Shares | Defined | 2021-11-04 | |
| 2020-12-31 | $72,466 | 150 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $149,461 | 267 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $155,912 | 250 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $48,829 | 100 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||